Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity

Int J Chron Obstruct Pulmon Dis. 2018 Oct 23:13:3511-3513. doi: 10.2147/COPD.S183736. eCollection 2018.

Igor Barjaktarevic¹, Robert Kaner^{2

3}, Russell G Buhr^{1

4}, Christopher B Cooper^{1

5}

¹ Division of Pulmonary and Critical Care, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, ibarjaktarevic@mednet.ucla.edu.
² Division of Pulmonary and Critical Care, Weill Cornell Medicine, NY, USA.
³ Department of Genetic Medicine, Weill Cornell Medicine, NY, USA.
⁴ Department of Health Policy and Management, Fielding School of Public Health at UCLA, Los Angeles, CA, USA.
⁵ Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

No abstract available

Publication types